Literature DB >> 32593129

Exosomes: Multiple-targeted multifunctional biological nanoparticles in the diagnosis, drug delivery, and imaging of cancer cells.

Yuzhong Zheng1, Anwarul Hasan2, Mohammad Mahdi Nejadi Babadaei3, Elham Behzadi4, Mina Nouri4, Majid Sharifi5, Mojtaba Falahati6.   

Abstract

Exosomes are biological nanoparticles (30-150 nm) secreted in the extracellular area from all of cells, that mediate intercellular message. Exosomes act as the carriers for numerous proteins, DNAs, RNAs and cell-signaling molecules. Therefore, exosomes secreted by the tumor cells are useful for diagnostic purposes because of their persistent presence in the blood and their provision of genetic cargo similar to those in tumor. Due to the risks of aggressive activity and ambiguity of biological activity in other tissues, the use of exosomes in drug delivery and imaging has been limited. However, their high loading, stability and longer circulation time, excellent targeting, high cell penetration performance, and optimal biodegradability have made them potential agents in targeted cancer treatment. Therefore, in addition to examining methods for isolating and loading exosomes, this paper discusses the applications of exosomes in biological measurement, imaging, and therapeutic activities. Also, this review describes the challenges of using exosomes compared to conventional methods and shows that it is very useful to use them due to less aggressive activities. Finally, this review attempts to provide an appropriate incentive by showing the performance of exosomes in cancer therapy through targeted drug delivery, gene therapy, imaging and diagnosis.
Copyright © 2020. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Diagnostic; Drug delivery; Exosome; Gene delivery; Imaging probes

Year:  2020        PMID: 32593129     DOI: 10.1016/j.biopha.2020.110442

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

Review 1.  An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment.

Authors:  Majid Sharifi; William C Cho; Asal Ansariesfahani; Rahil Tarharoudi; Hedyeh Malekisarvar; Soyar Sari; Samir Haj Bloukh; Zehra Edis; Mohamadreza Amin; Jason P Gleghorn; Timo L M Ten Hagen; Mojtaba Falahati
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

Review 2.  Regulation of ferroptosis by noncoding RNAs: a novel promise treatment in esophageal squamous cell carcinoma.

Authors:  Guanen Qiao; Wenjuan Zhang; Kui Dong
Journal:  Mol Cell Biochem       Date:  2022-04-21       Impact factor: 3.842

Review 3.  Exosomal MiRNAs in Osteosarcoma: Biogenesis and Biological Functions.

Authors:  Jinxin Tang; Jieyu He; Chengyao Feng; Chao Tu
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

4.  Exosome-derived SNHG16 sponging miR-4500 activates HUVEC angiogenesis by targeting GALNT1 via PI3K/Akt/mTOR pathway in hepatocellular carcinoma.

Authors:  Shuangda Li; Yu Qi; Yiran Huang; Yanru Guo; Tong Huang; Li Jia
Journal:  J Physiol Biochem       Date:  2021-08-23       Impact factor: 4.158

Review 5.  In Vivo Tracking of Extracellular Vesicles by Nuclear Imaging: Advances in Radiolabeling Strategies.

Authors:  Sara Almeida; Liliana Santos; Amílcar Falcão; Célia Gomes; Antero Abrunhosa
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

Review 6.  The Role of Exosomes and Their Applications in Cancer.

Authors:  Yuju Zhou; Ying Zhang; Huan Gong; Siqi Luo; Yan Cui
Journal:  Int J Mol Sci       Date:  2021-11-11       Impact factor: 5.923

Review 7.  Explaining chemical clues of metal organic framework-nanozyme nano-/micro-motors in targeted treatment of cancers: benchmarks and challenges.

Authors:  Mojtaba Falahati; Majid Sharifi; Timo L M Ten Hagen
Journal:  J Nanobiotechnology       Date:  2022-03-24       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.